药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Almasilate
Almasilate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magaldrate
Magaldrate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Pazopanib.
Podofilox
Eliglustat
The metabolism of Eliglustat can be decreased when combined with Pazopanib.
Podofilox
Teriflunomide
The serum concentration of Pazopanib can be decreased when it is combined with Teriflunomide.
Podofilox
Deferasirox
The serum concentration of Pazopanib can be increased when it is combined with Deferasirox.
Podofilox
Pitavastatin
Pitavastatin may increase the hepatotoxic activities of Pazopanib.
Podofilox
Mevastatin
Mevastatin may increase the hepatotoxic activities of Pazopanib.